Benzinga's Top Downgrades

Loading...
Loading...
Analysts at Piper Jaffray downgraded
Sarepta Therapeutics IncSRPT
from Neutral to Underweight. The target price for Sarepta Therapeutics has been lowered from $15 to $6. Sarepta Therapeutics shares fell 47.49 percent to $7.85 in pre-market trading. Bank of America downgraded
Canadian National Railway (USA) CNI
from Buy to Underperform. Canadian National Railway shares closed at $65.18 on Monday. Analysts at Deutsche Bank downgraded
U.S. BancorpUSB
from Buy to Hold. US Bancorp shares closed at $43.05 on Monday. Evercore ISI Group downgraded
Zions BancorporationZION
from Buy to Hold. Zions Bancorp shares dropped 2.57 percent to $26.59 in pre-market trading. Analysts at Cantor Fitzgerald downgraded
Whiting Petroleum Corp WLL
from Buy to Hold. Whiting Petroleum shares closed at $11.07 on Monday.
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: DowngradesAnalyst RatingsTop Downgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...